1)日本膵臓学会膵癌診療ガイドライン作成小委員会(編):科学的根拠に基づく膵癌診療ガイドライン.金原出版,2006
2)Pedrazzoli S, DiCarlo V, Dionigi R, et al:Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas:A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508-517, 1998
3)Yeo CJ, Cameron JL, Lillemoe KD, et al:Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2:Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355-368, 2002
4)Nguyen TC, Sohn TA, Cameron JL, et al:Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma:A prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7:1-11, 2003
5)Stojadinovic A, Hoos A, Brennan MF, et al:Randomized clinical trials in pancreatic cancer. Surg Oncol Clin N Am 11:207-229, 2002
6)Burris HA 3rd, Moore MJ, Andersen J, et al:Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:A randomized trial. J Clin Oncol 15:2403-2413, 1997
7)膵癌登録報告―2007.膵臓 22:e1-e427,2007
8)Imamura M, Doi R, Imaizumi T, et al:A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 136:1003-1011, 2004
9)Oettle H, Post S, Neuhaus P, et al:Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer:A randomized controlled trial. JAMA 297:267-277, 2007